




Searching News Database: regadenoson
HSMN NewsFeed - 23 Feb 2009
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
HSMN NewsFeed - 24 Apr 2008
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
HSMN NewsFeed - 16 Jul 2007
CV Therapeutics Names Lewis Stuart Senior Vice President, Commercial Operations
CV Therapeutics Names Lewis Stuart Senior Vice President, Commercial Operations
HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
HSMN NewsFeed - 14 Mar 2007
JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
HSMN NewsFeed - 26 Oct 2006
CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2006
CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2006
HSMN NewsFeed - 11 Oct 2006
CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets
CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets
HSMN NewsFeed - 19 Jun 2006
JACC Publishes ERICA Trial Results Showing Ranexa(R) Reduces Angina Frequency and Nitroglycerin Consumption
JACC Publishes ERICA Trial Results Showing Ranexa(R) Reduces Angina Frequency and Nitroglycerin Consumption
HSMN NewsFeed - 12 Jun 2006
PTC Therapeutics and CV Therapeutics Announce Collaboration and License Arrangement
PTC Therapeutics and CV Therapeutics Announce Collaboration and License Arrangement
HSMN NewsFeed - 9 May 2006
Angina Patients Cost Managed Care Over Twice as Much as Coronary Artery Disease Patients Without Angina
Angina Patients Cost Managed Care Over Twice as Much as Coronary Artery Disease Patients Without Angina
Additional items found! 14

Members Archive contains
14 additional stories matching:
regadenoson
(Password required)
regadenoson
(Password required)